MIRA
INFORM REPORT
|
Report Date : |
11.06.2007 |
IDENTIFICATION DETAILS
|
Name : |
IZOTÓP
INTÉZET KUTATÓ, |
|
|
|
|
Registered Office : |
1121
Budapest, Konkoly-Thege Miklós út 29-33. |
|
|
|
|
Country : |
Hungary |
|
|
|
|
Date of Incorporation : |
01/01/1993 |
|
|
|
|
Legal Form : |
Limited liability company (Ltd |
|
|
|
|
Line of Business : |
Manufacture of other organic basic chemicals |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
NAME & ADDRESS
Fejlesztő,
Termelő és Szolgáltató Korlátolt Felelősségű Társaság 1121
Budapest, Konkoly-Thege Miklós út 29-33. Phone: +36-1-3922574 Telefax: +36-1-3922573 E-Mail: comerce@izotop.hu Web: www.izotop.hu |
|
|
Legal form |
Limited liability company (Ltd.) |
|
|
Established on |
|
|
Registered on |
|
|
Registered capital |
|
HUF |
96 000 000 |
|
|
Owner |
Magyar
Tudományos Akadémia |
|
|
|
|
|
MTA Kémiai
Kutatóközpont |
|
|
|
|
|
dr. Forster
Tibor |
|
|
|
|
|
Falvi László |
|
|
|
|
|
Katovics György |
|
|
|
|
|
dr. Mucha István |
|
|
|
|
|
Komáromy Péter |
|
|
|
|
|
Kelemen Ferenc |
|
|
|
|
|
Alexin András |
|
|
|
|
|
Boldog Sándor |
|
|
|
|
|
Császár Gábor |
|
|
|
|
|
Dr. Korpás Gábor |
|
|
|
|
|
Fazekas Jolán |
|
|
|
|
|
Gyalókai Ferenc |
|
|
|
|
|
Gyöngy Istvánné |
|
|
|
|
|
Vellai László |
|
|
|
|
|
dr. Faiglné dr. Birkás
Erzsébet |
|
|
|
|
|
Hevér-Szabó Anna |
|
|
|
|
|
Kecskés László |
|
|
|
|
|
Komáromy Péter |
|
|
|
|
|
Lakatos
Gabriella |
|
|
|
|
|
Ledniczky Zoltán |
|
|
|
|
|
Molnárné Kele
Zsuzsanna |
|
|
|
|
|
Pálné Márton
Marianna |
|
|
|
|
|
Plósz Éva |
|
|
|
|
|
Rohrbacher
Márton |
|
|
|
|
|
Sasvári Sándorné |
|
|
|
|
|
Szabó Miklós |
|
|
|
|
|
Szende Judit |
|
|
|
|
|
Nagy István |
|
|
|
|
|
Papp Zoltán |
|
|
|
|
Manager |
dr. Faiglné dr.
Birkás Erzsébet |
|
|
dr. Környei
József |
|
|
Firle Imréné |
|
|
Kecskés László |
|
|
Lakatos Mihály |
|
|
Molnárné Kele
Zsuzsanna |
|
|
Szende Judit |
|
|
Tyukodi Lajos |
|
Supervisory
Board |
Dr. Boross
Zoltán |
|
|
Dr. Szilvási
István |
|
|
Dr. Tétényi Pál |
||||
|
Auditor |
Balla László |
|
|
|
|
|
|
PFCC
Könyvvizsgáló Korlátolt Felelősségű Társaság |
|
|
|
||
|
General data |
Main activity: |
(24.14) |
||||
|
|
Other
activities: |
(24.41) |
|
|
Manufacture of pharmaceutical preparations
|
(24.42) |
|
|
Manufacture of other general purpose
machinery nec |
(29.24) |
|
|
Manufacture of other special purpose
machinery nec |
(29.56) |
|
|
Manufacture of medical and surgical
equipment and orthopaedic applianc |
(33.10) |
|
|
Manufacture of instruments and appliances
for measuring, checking, tes |
(33.20) |
|
|
Wholesale trade of pharmaceutical goods |
(51.46) |
|
|
Freight transport by road |
(60.24) |
|
|
Research and experimental development on
natural sciences and engineer |
(73.10) |
|
|
Architectural and engineering activities
and related technical consult |
(74.20) |
|
|
Other business activities nec |
(74.87) |
|
|
Other human health activities |
(85.14) |
|
|
Name in foreign
language |
|
|
IZOTÓP INTÉZET Research, Development,
Production |
|
|
Isszledovatyelszkoje, opitnokonsztruktorszkoje,
proizvodsztvennoje i szervisznoje obscsesztvo sz ogr |
|
|
Export: |
|
|
Import: |
|
|
General
contacts: |
|
|
Residence
address: |
|
|
The company has ISO 9001 quality
certificate. |
|
|
Regular activity: |
|
|
manufacture of radioactive elements, |
|
|
isotopes, nuclear fuels, enzymes, |
|
|
medicals, otheer healthcare goods |
|
|
|
|
|
|
|
Employees |
2007. |
187 employees |
|||||
|
Annual turnover |
2000. |
Net income |
HUF |
1 418 839 000 |
|
||
|
|
2001. |
Net income |
HUF |
1 477 780 000 |
|
|
|
2002. |
Net income |
HUF |
1 573 288 000 |
|
|
|
2003. |
Net income |
HUF |
1 683 465 000 |
|
|
|
2004. |
Net income |
HUF |
1 975 887 000 |
|
|
|
2005. |
Net income |
HUF |
2 276 304 000 |
|
|
|
Property |
Company's property: Technological
equipments, machines, vehicles |
|||||
|
|
we do not have data about the real estate |
|
Balance sheets |
2005. évi mérleg (hivatalos forrás) ( |
|
|
2005. évi Éves beszámoló Összköltség eljárással készített er ( |
|
Remarks |
The enclosed balance sheet for 2004 is
originated from official source, we do not have information about the clause
of the auditor.
|
|
|
Main suppliers: |
|
|
- |
|
|
- SOLIN, |
|
|
- HARTMANN, |
|
|
- MERCK Vegyi és Gyógyszeripari Kft. |
|
|
- LINDE GÁZ Zrt. |
|
|
- THYSSENKRUPP FERROGLOBUS Zrt. |
|
|
|
|
Interests |
Interested party: |
9314058849 |
Dr. Tétényi Pál |
|
|
|
Interest: |
9310365712 |
KVALITEX Tudományos Technológiai Kereskedelmi Korlátolt
Felelősségű Társaság |
Manager |
|
|
Interested party: |
9314058849 |
Dr. Tétényi Pál |
|
|
|
Interest: |
9310365712 |
KVALITEX Tudományos Technológiai
Kereskedelmi Korlátolt Felelősségű Társaság |
Owner |
|
|
Interested party: |
9315177532 |
Magyar Tudományos Akadémia |
|
|
|
Interest: |
9311088418 |
ARCHEOSZTRÁDA Kutató, Szolgáltató és
Kereskedelmi Korlátolt felelősségű társaság |
Owner |
|
|
Interested party: |
9315140234 |
Tyukodi Lajos |
|
|
|
Interest: |
9310869704 |
HUNGAROSTER Kereskedelmi és Szolgáltató
Korlátolt Felelősségű Társaság |
Owner |
|
Bank relations |
CIB Bank Zrt
Medve u. fiók:
|
||
|
Company development |
Company development positive |
(21) |
|
|
Business course |
good |
(21) |
|
Terms of payment |
in so far as known, punctually |
(29) |
|
Business connection |
The establishing of the busness connection is allowed |
(21) |
|
|
Credit limit |
HUF 59 650 000 |
||
|
Legal agreement |
This |
|
Advertisement |
Database of "Hungarian TOP 500
companies" represented in HVG on 03.01.2007. had been revised of more
than 6500 companies (from official sources and company data). |
|
2005. évi mérleg (hivatalos forrás) ( |
|
Balance row |
A |
A <- B% |
B |
B <- C% |
C |
|
ASSETS INVESTED |
441 779 |
1 |
421 599 |
1,2 |
366 295 |
|
Intangible assets |
98 683 |
1,2 |
83 306 |
1,4 |
58 431 |
|
- Rights representing assets |
10 |
0,1 |
128 |
0,5 |
247 |
|
- Goodwill |
|
|
|
|
|
|
Advanced money given for intagible assets |
|
|
|
|
|
|
- Intellectual products |
4 254 |
0,8 |
5 516 |
1 |
5 317 |
|
- Capitalized value of experimental development |
94 419 |
1,2 |
77 662 |
1,5 |
52 867 |
|
- Capitalized value of incorporation/reorganization |
|
|
|
|
|
|
- Adjustment of the value of intangible assets |
|
|
|
|
|
|
Tangible assets |
342 446 |
1 |
337 643 |
1,1 |
307 123 |
|
- Immovables |
|
|
|
|
65 588 |
|
- Technological equipment, machinery and vehicles |
67 606 |
0,9 |
71 429 |
0,9 |
75 444 |
|
- Other equipment, appliances and vehicles |
39 552 |
1 |
40 718 |
3,1 |
13 164 |
|
animals for breeding |
|
|
|
|
|
|
- Investments |
182 350 |
1,1 |
166 546 |
1,1 |
152 747 |
|
- Advance payments made towards investments |
|
|
|
|
180 |
|
- Adjustment of the value of tangible assets |
|
|
|
|
|
|
Financial means invested |
650 |
1 |
650 |
0,9 |
741 |
|
- Securities |
41 175 |
1,3 |
30 931 |
|
|
|
Permanent interest in associated company |
|
|
|
|
|
|
Permanent loan given in associated company |
|
|
|
|
|
|
Other permanent interest |
|
|
|
|
|
|
Permanent loan given in other participating relation |
650 |
1 |
650 |
0,9 |
741 |
|
Other loan given to a longer period |
|
|
|
|
|
|
Security personifying permanent credit relation |
|
|
|
|
|
|
- Adjustment of the value of liquid assets invested |
|
|
|
|
|
|
Difference from capital consolidation |
|
|
|
|
|
|
CURRENT ASSETS |
640 477 |
1,3 |
492 043 |
1 |
492 130 |
|
Inventories |
75 398 |
1,3 |
57 042 |
0,9 |
63 137 |
|
- Materials |
61 800 |
1,3 |
46 933 |
1,1 |
44 240 |
|
- Commodities |
13 598 |
2,1 |
6 483 |
0,3 |
18 897 |
|
- Advance payments made towards inventories |
|
|
|
|
|
|
- Livestock |
|
|
|
|
|
|
- Incomplete production and semi-finished products |
|
|
|
|
|
|
- Finished products |
|
|
3 626 |
|
|
|
Accounts receivable |
466 621 |
1,6 |
294 896 |
0,8 |
359 260 |
|
- Receivables from clients on account of deliveries |
456 398 |
1,6 |
288 238 |
0,9 |
317 921 |
|
Receivables from associated company |
|
|
|
|
|
|
Receivables from other participating relation |
|
|
|
|
|
|
- Bills receivable |
|
|
|
|
|
|
- Other receivables |
10 223 |
1,5 |
6 658 |
0,2 |
41 339 |
|
Tax reclaimable (as estimated) as a result of consolidation |
|
|
|
|
|
|
Securities |
|
|
|
|
30 063 |
|
Interest in associated company |
|
|
|
|
|
|
Other interest |
|
|
|
|
|
|
Securities personifying circulational credit relation aim |
41 175 |
1,3 |
30 931 |
|
|
|
Treasury stock, business quotas |
|
|
|
|
|
|
Liquid assets |
57 283 |
0,5 |
109 174 |
2,8 |
39 670 |
|
- Cash at hand and cheques |
2 698 |
1,6 |
1 689 |
1,1 |
1 491 |
|
- Bank deposits |
54 585 |
0,5 |
107 485 |
2,8 |
38 179 |
|
ACCRUED AND DEFERRED ASSETS |
11 729 |
4,9 |
2 371 |
0,5 |
4 602 |
|
Accrued and deferred assets of revenues |
19 |
0,0 |
508 |
0,4 |
1 212 |
|
Accrued and deferred assets of expenses, expenditures |
11 710 |
6,3 |
1 863 |
0,5 |
3 390 |
|
Postponed expenditures |
|
|
|
|
|
|
TOTAL ASSETS |
1 093 985 |
1,2 |
916 013 |
1,1 |
863 027 |
|
SHAREHOLDERS' EQUITY |
459 335 |
1,1 |
405 325 |
1,2 |
328 475 |
|
Capital subscribed |
96 000 |
1 |
96 000 |
1,1 |
86 000 |
|
own shares redeemed at par value |
|
|
|
|
|
|
Capital subscribed but not yet paid |
|
|
|
|
|
|
Capital reserve |
|
|
|
|
|
|
Profit reserve |
214 906 |
1,3 |
164 813 |
1 |
171 109 |
|
Locked-up reserve |
94 419 |
1,2 |
77 662 |
1,5 |
52 866 |
|
Provision for re-evaluation differences |
|
|
|
|
|
|
Result as per balance-sheet |
54 010 |
0,8 |
66 850 |
3,6 |
18 500 |
|
-- changes in the equity of the mother company |
|
|
|
|
|
|
-- changes in consequence of the consolidation |
|
|
|
|
|
|
-- changes arising from the difference of debt |
|
|
|
|
|
|
-- changes arising from the difference of interim |
|
|
|
|
|
|
.- Participations of external members (other owners) |
|
|
|
|
|
|
SPECIFIC RESERVES |
|
|
|
|
|
|
Specific reserves for anticipated liabilities |
|
|
|
|
|
|
Provisions for the future expenses |
|
|
|
|
|
|
Other provisions |
|
|
|
|
|
|
LIABILITIES |
493 895 |
1,3 |
391 053 |
1 |
406 033 |
|
Other liabilities |
|
|
|
|
|
|
Long-term liabilities |
24 220 |
0,5 |
51 699 |
1 |
51 748 |
|
- Investment and development credits |
|
|
13 292 |
0,4 |
33 190 |
|
- Other long-term credits |
|
|
|
|
|
|
- Long-term loans received |
6 000 |
0,5 |
11 245 |
0,8 |
14 920 |
|
Convertible securities |
|
|
|
|
|
|
- Debts assumed on the issue of bonds |
|
|
|
|
|
|
Permanent liabilities to associated company |
|
|
|
|
|
|
Permanent liabilities to other participating relation |
|
|
|
|
|
|
- Other long-term liabilities |
18 220 |
0,7 |
27 162 |
7,5 |
3 638 |
|
Difference of capital consolidation arising from the affiliated
companies |
|
|
|
|
|
|
Short-term liabilities |
469 675 |
1,4 |
339 354 |
1 |
354 285 |
|
- Advance payments received from customers |
3 157 |
0,1 |
29 145 |
|
|
|
- Liabilities from deliveries |
297 637 |
2,3 |
130 491 |
0,8 |
172 433 |
|
- Bills payable |
|
|
|
|
|
|
Short-term liabilities towards affiliated companies |
|
|
|
|
|
|
Short-term liabilities towards companies in which other participations
are held |
|
|
|
|
|
|
- Short-term credits |
56 613 |
0,8 |
66 884 |
0,9 |
72 074 |
|
- Short-term loans |
|
|
20 354 |
0,7 |
30 075 |
|
from this: convertible securities |
|
|
|
|
|
|
- Other short-term liabilities |
112 268 |
1,2 |
92 478 |
1,2 |
79 703 |
|
Estimated tax arrears resulting from the consolidation |
|
|
|
|
|
|
ACCRUED EXPENSES |
140 755 |
1,2 |
119 635 |
0,9 |
128 519 |
|
Accrued expenses of revenues |
|
|
|
|
|
|
Accrued expenses of costs, expenditures |
38 398 |
1,3 |
30 688 |
0,6 |
48 762 |
|
Postponed revenues |
102 357 |
1,2 |
88 947 |
1,1 |
79 757 |
|
TOTAL LIABILITIES |
1 093 985 |
1,2 |
916 013 |
1,1 |
863 027 |
|
Balance indices |
A |
|
B |
|
C |
|
Liquidity 1 |
1.3637 |
|
1.4499 |
|
1.3891 |
|
Liquidity 2 |
1.2031 |
|
1.2819 |
|
1.2109 |
|
Rate of sources (Liabilities/Shareholders' equity) |
107.52% |
|
96.48% |
|
123.61% |
|
Rate of tangible assets (Tangible assets/Fixed assets) |
31.30% |
|
36.86% |
|
35.59% |
|
Rate of current assets (Current assets/Fixed assets) |
58.55% |
|
53.72% |
|
57.02% |
|
Capital (Shareholders' equity/Sources) |
41.99% |
|
44.25% |
|
38.06% |
|
Measure of indebtedness (liability / all sources) |
45.15% |
|
42.69% |
|
47.05% |
|
Security of fixed assets (shrhldr's equity / fixed assets) |
103.97% |
|
96.14% |
|
89.67% |
|
Liquidation acid test ratio: financial assets/ current liabilities |
12.20% |
|
32.17% |
|
11.20% |
|
A. 2005. évi Éves beszámoló Összköltség eljárással készített er ( |
|
Balance row |
A |
A <- B% |
B |
B <- C% |
C |
|
- Net returns from domestic sales |
916 853 |
1,1 |
861 113 |
1,1 |
777 476 |
|
- Net returns from |
1 359 451 |
1,2 |
1 114 774 |
1,2 |
905 989 |
|
Net returns from sales |
2 276 304 |
1,2 |
1 975 887 |
1,2 |
1 683 465 |
|
Other revenues |
15 319 |
0,2 |
92 530 |
3,4 |
26 871 |
|
- Capitalized value of assets of own production |
56 207 |
2,3 |
24 795 |
1,9 |
13 128 |
|
- Changes in the stock of inventories compiled from own products |
|
|
3 626 |
|
|
|
Capitalized value of own performance |
56 207 |
2 |
28 422 |
2,2 |
13 128 |
|
Depreciation |
811 |
0,8 |
1 037 |
|
|
|
- Material costs |
557 541 |
1,2 |
470 458 |
2 |
240 647 |
|
- Value of material-type services the Company availed itself of |
311 582 |
1,3 |
242 705 |
1,2 |
208 249 |
|
Value of other deliveries |
94 392 |
1 |
93 341 |
1,1 |
83 161 |
|
- Purchase value of the goods sold |
434 463 |
1 |
423 875 |
1,1 |
388 167 |
|
Value of sold (intermediate) services |
39 942 |
1,5 |
26 300 |
0,6 |
45 337 |
|
Material--type costs |
1 437 921 |
1,1 |
1 256 680 |
1,3 |
965 561 |
|
- Wages and salaries |
507 307 |
1,1 |
442 388 |
1,1 |
415 691 |
|
- Other staff emoluments |
41 193 |
1,1 |
37 271 |
0,6 |
65 524 |
|
Payment contributions |
179 757 |
1,1 |
158 698 |
1 |
153 042 |
|
Staff costs |
728 257 |
1,1 |
638 356 |
1 |
634 257 |
|
Depreciation |
45 980 |
1,1 |
42 862 |
1,1 |
38 976 |
|
Other expenditures |
74 481 |
1,3 |
58 398 |
1,7 |
35 355 |
|
Depreciation |
1 236 |
1,5 |
811 |
0,7 |
1 129 |
|
TRADING PROFIT/INCOME FROM OPERATIONS |
61 191 |
0,6 |
100 543 |
2 |
49 315 |
|
Interest receivable and similar income |
|
|
|
|
66 |
|
Given to associated company |
|
|
|
|
|
|
Dividends received and profit sharing |
|
|
|
|
|
|
Received from associated company |
|
|
|
|
|
|
Depreciation of selling the interests |
|
|
|
|
|
|
Received from associated company |
|
|
|
|
|
|
Exchange profit and interest of the invested liquid assets |
|
|
|
|
2 222 |
|
Received from associated company |
|
|
|
|
|
|
Other revenues from financial transactions |
29 486 |
1,3 |
22 220 |
1,2 |
19 246 |
|
Revenues from financial transactions |
32 879 |
1,2 |
28 139 |
1,3 |
21 534 |
|
Depreciation of the invested liquid assets |
|
|
|
|
|
|
Given to associated company |
|
|
|
|
|
|
Interest paid and interest related expenses |
5 644 |
0,8 |
6 702 |
1 |
6 584 |
|
Given to associated company |
|
|
|
|
|
|
Depreciation of interests, shares and bank deposits |
|
|
|
|
|
|
Other expenditures on financial. transactions |
16 824 |
0,5 |
35 131 |
1,3 |
27 132 |
|
Expenses on financial transactions |
22 468 |
0,5 |
41 833 |
1,2 |
33 716 |
|
PROFIT FROM FINANCIAL TRANSACTIONS |
10 411 |
-0,8 |
-13 694 |
1,1 |
-12 182 |
|
PROFIT FROM ORDINARY ACTIVITIES |
71 602 |
0,8 |
86 849 |
2,3 |
37 133 |
|
Extraordinary incomes |
3 269 |
4 |
817 |
5,6 |
145 |
|
Extraordinary expenditures |
190 |
1,3 |
145 |
0,5 |
265 |
|
EXTRAORDINARY PROFITS |
3 079 |
4,6 |
672 |
-5,6 |
-120 |
|
PRE-TAX PROFITS |
74 682 |
0,9 |
87 522 |
2,4 |
37 013 |
|
Tax payable |
|
|
|
|
|
|
AFTER-TAX PROFIT |
74 682 |
0,9 |
87 522 |
2,4 |
37 013 |
|
Use of accumulated profit reserve for dividends and profit sharing |
|
|
|
|
|
|
Dividend and profit sharing approved and paid |
20 672 |
1 |
20 672 |
1,1 |
18 514 |
|
PROFIT AS PER BALANCE-SHEET |
54 010 |
0,8 |
66 850 |
3,6 |
18 500 |
|
Balance indices |
A |
|
B |
|
C |
|
Rentability |
3.28% |
|
4.43% |
|
2.20% |
|
Annual change of the net return of sales |
15.20% |
|
17.37% |
|
7.00% |
|
|
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)